{
  "retracted": false,
  "timestamp": 1581033600000,
  "updates": [
    {
      "timestamp": 1591740707764,
      "identifier": {
        "doi": "10.1007/s00415-020-09715-5"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s00415-019-09602-8"
  },
  "journal": "Journal of Neurology",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis"
}
